| Erik A Scharrer, MD | |
|
1025 Marsh St, Mankato, MN 56001-4752 | |
| (507) 389-4700 | |
| Not Available |
| Full Name | Erik A Scharrer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 13 Years |
| Location | 1025 Marsh St, Mankato, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245525484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 72477 (Wisconsin) | Secondary |
| 207P00000X | Emergency Medicine | 56712 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System-new Prague | New prague, MN | Hospital |
| Mayo Clinic Health System - Mankato | Mankato, MN | Hospital |
| Mayo Clinic Health System In Red Wing | Red wing, MN | Hospital |
| Mayo Clinic Health System - Fairmont | Fairmont, MN | Hospital |
| Mayo Clinic Health System - Albert Lea And Austin | Albert lea, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southeast Minnesota Region | 4385556703 | 573 |
| Mayo Clinic Health System-southwest Minnesota Region | 4688585771 | 533 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-lake City |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164463659 PECOS PAC ID: 1951213487 Enrollment ID: O20031104000095 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891701637 PECOS PAC ID: 4385556703 Enrollment ID: O20031104000408 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-fairmont |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366410862 PECOS PAC ID: 4981694981 Enrollment ID: O20040719000142 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System St James |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023177730 PECOS PAC ID: 9537170352 Enrollment ID: O20060509000021 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-lake City |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1538113022 PECOS PAC ID: 1951213487 Enrollment ID: O20070711000490 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System St James |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1639198732 PECOS PAC ID: 9537170352 Enrollment ID: O20080108000344 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740256668 PECOS PAC ID: 4688585771 Enrollment ID: O20171011003933 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1124035282 PECOS PAC ID: 4688585771 Enrollment ID: O20171011003939 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1063435410 PECOS PAC ID: 4385556703 Enrollment ID: O20171011003946 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erik A Scharrer, MD 1015 Marsh St, Mankato, MN 56001-4752 Ph: (507) 389-4700 | Erik A Scharrer, MD 1025 Marsh St, Mankato, MN 56001-4752 Ph: (507) 389-4700 |
News Archive
In the current issue of Family Medicine and Community Health (Volume 6,Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0118: , Somayeh Zare, Mehdi Kargar, Jeyran Ostovarfar, Mohammad Hossein Kaveh of the Department of the Health Education and Promotion, School of Health, Shiraz University of Medical Science, Shiraz, Iran discuss how studies show that suitable design of educational programs can affect prisoners' awareness of AIDS.
To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 5 days ago
Stuart E Clive, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Benjamin D Knutson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-284-2511 | |
Dr. Robert Bosse, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1230 E Main St, Mankato, MN 56001 Phone: 507-625-1811 | |
David Joseph Gresback, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1025 Marsh St Dept Of, Mankato, MN 56001 Phone: 507-385-2610 | |
Dr. Linda Sara Russo, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Michael R Gartner, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Mayo Clinic Health System, 1025, Mankato, MN 56001 Phone: 507-624-4031 Fax: 507-624-4031 | |
Andrew Lee Matthews, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4549 |